Progressive cerebral atrophy in multiple sclerosis A serial MRI study

Brain

Volumn 119, Issue 6, 1996, Pages 2009-2019

  Losseff, N A ^a   Wang, L ^a   Lai, H M ^a   Yoo, D S ^b   Gawne Cain, M L ^a   McDonald, W I ^a   Miller, D H ^a   Thompson, A J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cerebral atrophy; Clinical measurement; Disability; Gadolinium enhancement; Lesion load; MRI; Multiple sclerosis

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM;

ADULT; ALGORITHM; ARTICLE; BRAIN ATROPHY; CEREBELLUM; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DISABILITY; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; MEASUREMENT; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PATIENT MONITORING; PRIORITY JOURNAL; REPRODUCIBILITY; SCORING SYSTEM; SPINAL CORD; WHITE MATTER;

ADULT; ATROPHY; BRAIN; DISABILITY EVALUATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 0030453516     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/119.6.2009     Document Type: Article

References (32)

1. Bentson J, Reza M, Winter J, Wilson G. Steroids and apparent cerebral atrophy on computed tomography scans. J Comput Assist Tomogr 1978; 2: 16-23.
2. Blatter DD, Bigler ED, Gale SD, Johnson SC, Anderson CV, Burnett BM, et al. Quantitative volumetric analysis of brain MR: normative database spanning 5 decades of life. AJNR Am J Neuroradiol 1995; 16: 241-51.
3. British Standards Institution. Precision of test methods I: guide for the determination and reproducibility for a standard test method (BS 5497, part 1). London: British Standards Institution, 1979.
4. Brownell B, Hughes JT. The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 1962; 25: 315-20.
5. Comi G, Filippi M, Martinelli V, Sirabian G, Visciani A, Campi A, et al. Brain magnetic resonance imaging correlates of cognitive impairment in multiple sclerosis. J Neurol Sci 1993; 115 Suppl: S66-S73.
6. Davie CA, Barker GJ, Webb S, Tofts PS, Thompson AJ, Harding AE, et al. Persistant functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 1995; 118: 1583-92.
7. Feinstein A, Ron M, Thompson A. A serial study of psychometric and magnetic resonance imaging changes in multiple sclerosis. Brain 1993; 116: 569-602.
8. Francis DA, Bain P, Swan AV, Hughes RAC. An assessment of disability rating scales used in multiple sclerosis. Arch Neurol 1991; 48: 299-301.
9. Goodkin DE. EDSS reliability [letter; comment]. Neurology 1991; 41: 332. Comment on: Neurology 1990; 40: 971-5.
10. Goodkin DE. EDSS reliability [letter; comment]. Neurology 1991; 41: 332. Comment on: Neurology 1990; 40: 971-5.
11. Goodkin DE, Ross JS, Medendorp SV, Konecsni J, Rudick RA. Magnetic resonance imaging lesion enlargement in multiple sclerosis. Disease-related activity, chance occurrence, or measurement artifact? Arch Neurol 1992; 49: 261-3.
12. Grimaud J, Lai M, Thorpe J, Adeleine P, Plummet D, Barker G, et al. Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques. Magn Reson Imaging 1996. In press.
13. Gross KR, Tomberg TA, Kokk AA, Kaasik AE. [The prognosis of multiple sclerosis: computed tomographic comparisons]. [Russian]. Zh Nevropatol Psikhiatr Im S S Korsakova 1993; 93: 32-5.
14. Hageleit U, Will CH, Seidel D. Automated measurements of cerebral atrophy in multiple sclerosis. Neurosurg Rev 1987; 10: 137-40.
15. Huber SJ, Paulson GW, Shuttleworth EC, Chakeres D, Clapp LE, Pakalnis A, et al. Magnetic resonance imaging correlates of dementia in multiple sclerosis. Arch Neurol 1987; 44: 732-6.
16. Kidd D, Thorpe JW, Kendall BE, Barker GJ, Miller DH, McDonald WI, et al. MRI dynamics of brain and spinal cord in progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 1996; 60: 15-19.
17. Kohlmeyer K, Lehmkuhl G, Poutska F. Computed tomography of anorexia nervosa. AJNR Am J Neuroradiol 1983; 4: 437-8.
18. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
19. Loizou LA, Rolfe EB, Hewazy H. Cranial computed tomography in the diagnosis of multiple sclerosis. J Neurol Neurosurg Psychiatry 1982; 45: 905-12.
20. Losseff NA, Webb SL, O'Riordan JI, Page R, Wang L, Barker GJ, et al. Spinal cord atrophy and disability in multiple sclerosis: a new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996a; 119: 701-8.
21. Losseff NA, Kingsley DPE, McDonald WI, Miller DH, Thompson AJ. Clinical and magnetic resonance imaging predictors of disability in primary and secondary progressive multiple sclerosis. Multiple Sclerosis 1996b; 1: 218-22.
22. Mellanby AR, Reveley MA. Effects of acute dehydration on computerized tomographic assessment of cerebral density and ventricular volume [letter]. Lancet 1982; 2: 874.
23. Miller DH, Albert PS, Barkhof F, Francis G, Frank JA, Hodgkinson S, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 1996; 39: 6-16.
24. Noseworthy JH, Paty DW, Ebers GC. Neuroimaging in multiple sclerosis. Neurol Clin 1984; 2: 759-77.
25. Pfefferbaum A, Mathalon DH, Sullivan EV, Rawles JM, Zipursky RB, Lim KO. A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch Neurol 1994; 51: 874-87.
26. Polman CH, Dahlke F, Thompson AJ, Ghazi M, Kappos L, Miltenburger C, et al. Interferon beta-1b in secondary progressive multiple sclerosis - outline of the clinical trial. Multiple Sclerosis 1995; 1 Suppl. 1: S51-S54.
27. Rao SM, Glatt S, Hammeke TA, McQuillen MP, Khatri BO, Rhodes AM, et al. Chronic progressive multiple sclerosis. Relationship between cerebral ventricular size and neuropsychological impairment. Arch Neurol 1985; 42: 678-82.
28. Ron MA, Acker W, Shaw GK, Lishman WA. Computerized tomography of the brain in chronic alcoholism: a survey and followup study. Brain 1982; 105: 497-514.
29. Smith ME. Stone LA, Albert PS, Frank JA, Martin R, Armstrong M, et al. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol 1993; 33: 480-9.
30. van Oosten BW, Lai M, Hodgkinson S, Barkhof F, Miller DH, Moseley IF, et al. Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled. MR-monitored phase II trial. Neurology 1996. In press.
31. 1-weighted) spin-echo images. Neurology 1995; 45: 1684-90.
32. Yoo DS, Lemieux L, Arridge SR, Tofts PS. Segmentation of skull contours in MR head images. Proc Soc Magn Res 1995; 2: 707.